Cancer

Views & Analysis

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Marc Moodley has worked at Sanofi since 2018 and is the new medical head, UK and Ireland for the company’s Genzyme unit.

News

Boehringer cleared to manufacture BeiGene's cancer drug for ...

Boehringer Ingelheim is to manufacture the first biologic drug approved in China using a new regulatory system, designed to strengthen the country’s domestic pharma infrastructure.

News

FDA hastily approves Daiichi Sankyo/AZ's cancer drug, weeks ...

The FDA has approved an advanced breast cancer drug from AstraZeneca and Daiichi Sankyo in super-quick time.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J to buy US biotech Taris and its bladder cancer drug devi...

Johnson & Johnson is to buy the privately-owned biotech Taris, and a device that can deliver cancer drugs to the bladder.

News

AZ sells ex-US rights to old cancer drugs Arimidex and Casod...

For several years AstraZeneca has been selling off rights to its older drugs to raise cash as it develops a new generation of drugs, and this pattern has continued as it sold its Arimidex a

News

PharmaMar and Jazz sign $1bn US deal for lung cancer drug lu...

Spain's PharmaMar and Jazz Pharmaceuticals have signed a $1 billion license agreement for the lung cancer drug lurbinectedin in the US, which is being teed up for a launch in 2020.

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Boehringer cleared to manufacture BeiGene's cancer drug for ...

FDA hastily approves Daiichi Sankyo/AZ's cancer drug, weeks ...

J&J to buy US biotech Taris and its bladder cancer drug devi...

AZ sells ex-US rights to old cancer drugs Arimidex and Casod...

PharmaMar and Jazz sign $1bn US deal for lung cancer drug lu...

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks